PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clincal Trial and Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Department of Hematology, Wuhan No. 1 Hospital, Wuhan, China.\', \'Hematology Department of The Third Xiangya Hospital Central South University, Changsha, China.\', \'Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, China.\', \'Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children\'s Hospital Medical Center, Cincinnati, Ohio. Electronic address: Gang.Huang@cchmc.org.\', \'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: wwang@vip.126.com.\', \'Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clincal Trial and Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: jfzhou@tjh.tjmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0091-6749(20)30738-710.1016/j.jaci.2020.05.019
?:doi
?:hasPublicationType
?:journal
  • The Journal of allergy and clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 32470486
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32470486>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32470486>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all